Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q3 2023 · 10-Q
Revenue$27.57M$27.57M+34.5% vs Q3 2022 Net Income$527.00K$527.00KN/M vs Q3 2022 EPS Diluted$0.12$0.12N/M vs Q3 2022 Gross Profit$5,603,000+69.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$304,000N/M Free Cash Flowderived-$305,000N/M Margins · derivedGross margin20.3%+4.1 pt vs Q3 2022
Operating margin2.5%+11.9 pt vs Q3 2022
Net margin1.9%+9.8 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 14, 2023 · 45 d after period end